BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29952293)

  • 21. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
    Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
    Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyoderma gangrenosum masquerading as dermatitis artefacta.
    Harries MJ; McMullen E; Griffiths CE
    Arch Dermatol; 2006 Nov; 142(11):1509-10. PubMed ID: 17116850
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.
    Low ZM; Mar A
    Australas J Dermatol; 2018 May; 59(2):131-134. PubMed ID: 29205260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyoderma gangrenosum successfully treated with cyclosporin A.
    V'lckova-Laskoska MT; Laskoski DS; Caca-Biljanovska NG; Darkoska JS
    Adv Exp Med Biol; 1999; 455():541-5. PubMed ID: 10599396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pyoderma gangrenosum is 100 years old. From Louis Brocq to biotherapies].
    Farhi D; Wallach D; Avril MF
    Rev Prat; 2008 Feb; 58(4):457-61. PubMed ID: 18506988
    [No Abstract]   [Full Text] [Related]  

  • 27. Pyoderma gangrenosum triggered by switching from adalimumab to secukinumab.
    Jin K; Matsuzaki Y; Akasaka E; Nakano H; Sawamura D
    J Dermatol; 2019 Mar; 46(3):e108-e109. PubMed ID: 30192400
    [No Abstract]   [Full Text] [Related]  

  • 28. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pyoderma gangrenosum. 15 cases].
    Riahi I; Mokni M; Haouet S; Cherif F; El Euch D; Azaiz MI; Zitouna MM; Ben Osman-Dhahri A
    Ann Med Interne (Paris); 2001 Feb; 152(1):3-9. PubMed ID: 11240419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment with ustekinumab and vacuum-assisted closure therapy in recalcitrant myelodysplastic syndrome-associated pyoderma gangrenosum: case report and literature review.
    Nieto D; Sendagorta E; Rueda JM; Herranz P
    Clin Exp Dermatol; 2019 Jan; 44(1):116-119. PubMed ID: 29851121
    [No Abstract]   [Full Text] [Related]  

  • 31. Coexistence of pustular and vegetative pyoderma gangrenosum in a patient with myelodysplastic syndrome.
    Omiya W; Ujiie H; Akiyama M; Izumi K; Shigematsu A; Onozawa M; Shimizu H
    Eur J Dermatol; 2012; 22(5):711-2. PubMed ID: 22858442
    [No Abstract]   [Full Text] [Related]  

  • 32. Coexisting pustular and ulcerative pyoderma gangrenosum.
    Nakano S; Oiso N; Kawada A
    Eur J Dermatol; 2012; 22(1):153-4. PubMed ID: 22067845
    [No Abstract]   [Full Text] [Related]  

  • 33. Pyoderma gangrenosum associated with sarcoidosis.
    Kontochristopoulos G; Saxioni E; Doulaveri-Gherasim G; Politis G; Zakopoulou N
    Acta Derm Venereol; 2003; 83(2):153-4. PubMed ID: 12735656
    [No Abstract]   [Full Text] [Related]  

  • 34. Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.
    Sakamoto T; Hashimoto T; Furukawa F
    Eur J Dermatol; 2002; 12(5):485-7. PubMed ID: 12370142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pyoderma gangrenosum and Behçet's disease: a study of two pediatric cases].
    Hali F; Khadir K; Chiheb S; Bouayad K; Mikou N; Benchikhi H
    Arch Pediatr; 2011 Dec; 18(12):1320-3. PubMed ID: 22030347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ulcerative pyoderma gangrenosum.
    Sander M; Sander M
    CMAJ; 2019 Sep; 191(38):E1058. PubMed ID: 31548193
    [No Abstract]   [Full Text] [Related]  

  • 37. Pyoderma gangrenosum with liver, spleen and bone involvement in a patient with chronic myelomonocytic leukaemia.
    Vadillo M; Jucgla A; Podzamczer D; Rufi G; Domingo A
    Br J Dermatol; 1999 Sep; 141(3):541-3. PubMed ID: 10583064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple pulmonary nodules in association with pyoderma gangrenosum.
    Kasuga I; Yanagisawa N; Takeo C; Koga M; Kiyokawa H; Yonemaru M; Ichinose Y; Toyama K
    Respir Med; 1997 Sep; 91(8):493-5. PubMed ID: 9338053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scrotal pyoderma gangrenosum associated with dermatomyositis.
    Shah M; Lewis FM; Harrington CI
    Clin Exp Dermatol; 1996 Mar; 21(2):151-3. PubMed ID: 8759207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated superficial porokeratosis and pyoderma gangrenosum.
    di Meo N; Fluehler C; Perkan V; Trevisan G
    Dermatol Online J; 2010 Oct; 16(10):15. PubMed ID: 21062609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.